NO901082L - Fremgangsmaate for fremstilling av tetrahydrokinolin-derivater. - Google Patents

Fremgangsmaate for fremstilling av tetrahydrokinolin-derivater.

Info

Publication number
NO901082L
NO901082L NO90901082A NO901082A NO901082L NO 901082 L NO901082 L NO 901082L NO 90901082 A NO90901082 A NO 90901082A NO 901082 A NO901082 A NO 901082A NO 901082 L NO901082 L NO 901082L
Authority
NO
Norway
Prior art keywords
tetrahydroquinoline
dichloro
carboxy
methoxycarbonyl
benzylcarbonylamino
Prior art date
Application number
NO90901082A
Other languages
English (en)
Norwegian (no)
Other versions
NO901082D0 (no
Inventor
Raymond Baker
William R Carling
Paul D Leeson
Julian D Smith
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898905334A external-priority patent/GB8905334D0/en
Priority claimed from GB898926431A external-priority patent/GB8926431D0/en
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of NO901082D0 publication Critical patent/NO901082D0/no
Publication of NO901082L publication Critical patent/NO901082L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Other Liquid Machine Or Engine Such As Wave Power Use (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO90901082A 1989-03-08 1990-03-07 Fremgangsmaate for fremstilling av tetrahydrokinolin-derivater. NO901082L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898905334A GB8905334D0 (en) 1989-03-08 1989-03-08 Therapeutic agents
GB898926431A GB8926431D0 (en) 1989-11-22 1989-11-22 Therapeutic agents

Publications (2)

Publication Number Publication Date
NO901082D0 NO901082D0 (no) 1990-03-07
NO901082L true NO901082L (no) 1990-09-10

Family

ID=26295073

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90901082A NO901082L (no) 1989-03-08 1990-03-07 Fremgangsmaate for fremstilling av tetrahydrokinolin-derivater.

Country Status (11)

Country Link
EP (1) EP0386839B1 (de)
JP (1) JPH0334969A (de)
KR (1) KR900014321A (de)
AT (1) ATE147732T1 (de)
AU (1) AU5114490A (de)
CA (1) CA2011686A1 (de)
DE (1) DE69029668T2 (de)
FI (1) FI901148A7 (de)
IL (1) IL93610A0 (de)
NO (1) NO901082L (de)
PT (1) PT93362A (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5268378A (en) * 1990-05-31 1993-12-07 Merck Sharp & Dohme, Limited Dioxo-tetrahydroquinoline derivatives
US5401848A (en) * 1990-11-26 1995-03-28 E. R. Squibb & Sons, Inc. Indane and quinoline derivatives
DE69210229T2 (de) * 1991-02-27 1996-11-14 Merrell Pharmaceuticals Inc., Cincinnati, Ohio Dihydrochinolin NMDA Antagonisten
US5606063A (en) * 1991-02-27 1997-02-25 Merrell Pharmaceuticals Inc. NMDA antagonists
GB9109007D0 (en) * 1991-04-26 1991-06-12 Merck Sharp & Dohme Therapeutic method
FR2683818B1 (fr) * 1991-11-14 1993-12-31 Adir Cie Nouveaux derives de 3-sulfonylamino-2-(1h)-quinoleinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
GB9125515D0 (en) * 1991-11-29 1992-01-29 Merck Sharp & Dohme Therapeutic agents
ATE221520T1 (de) * 1995-09-29 2002-08-15 Glaxo Wellcome Spa Tetrahydrochinoline als nmda antagonisten
GB9617305D0 (en) * 1996-08-17 1996-09-25 Glaxo Wellcome Spa Heterocyclic compounds
DE19705133A1 (de) * 1997-02-11 1998-08-13 Hoechst Ag Sulfonamid-substituierte Verbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
GB9706294D0 (en) * 1997-03-26 1997-05-14 Glaxo Wellcome Spa Heterocyclic compound
MY125037A (en) * 1998-06-10 2006-07-31 Glaxo Wellcome Spa 1,2,3,4 tetrahydroquinoline derivatives
US6197786B1 (en) * 1998-09-17 2001-03-06 Pfizer Inc 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines
EP1607389A1 (de) * 1999-09-10 2005-12-21 Pfizer Products Inc. 4-geschützte-amino-2-substituierte-1,2,3,4-Tetrahydrochinolin-Derivate zur Verwendung als Zwischenprodukte für CETP-Inhibitoren
DE10000311A1 (de) 2000-01-05 2001-07-12 Gruenenthal Gmbh Aminomethyl-Phonyl-Cyclohexanonderivate
DE10005302A1 (de) * 2000-02-07 2002-01-17 Gruenenthal Gmbh Substituierte 1,2,3,4-Tetrahydrochinolin-2-carbonsäurederivate
WO2002046185A1 (en) * 2000-12-07 2002-06-13 Japan Science And Technology Corporation Intermediates for synthesis of vinblastine compound and method of synthesizing the intermediates
DE10132725A1 (de) 2001-07-05 2006-08-03 Grünenthal GmbH Substituierte γ-Lactonverbindungen
DE10137487A1 (de) * 2001-08-03 2003-03-27 Gruenenthal Gmbh Substituierte 5,6,6a,11b-Tetrahydro-7-oxa-6-aza- benzo[c]fluoren-6-carbonsäurederivate
DE10137488A1 (de) * 2001-08-03 2003-02-20 Gruenenthal Gmbh Salze substituierter 1,2,3,4-Tetrahydrochinolin-2-carbonsäurederivate
EP2527339A1 (de) * 2004-11-24 2012-11-28 Abbott Laboratories Chromanylharnstoffverbindungen, die den Vanilloidrezeptor-Subtyp 1 (VR1)-Rezeptor hemmen und Verwendungen davon
TW200808731A (en) 2006-03-30 2008-02-16 Tanabe Seiyaku Co A process for preparing tetrahydroquinoline derivatives
EP3427729A1 (de) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid zur behandlung von epileptischen erkrankungen, störungen oder zuständen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH23848A (en) * 1985-05-24 1989-11-23 Ciba Geigy Ag Certain phosphonic acids and derivatives
GB8719102D0 (en) * 1987-08-12 1987-09-16 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
CA2011686A1 (en) 1990-09-08
FI901148A0 (fi) 1990-03-07
FI901148A7 (fi) 1990-09-09
EP0386839A3 (de) 1991-10-23
PT93362A (pt) 1990-11-07
DE69029668D1 (de) 1997-02-27
EP0386839A2 (de) 1990-09-12
ATE147732T1 (de) 1997-02-15
AU5114490A (en) 1990-09-13
KR900014321A (ko) 1990-10-23
DE69029668T2 (de) 1997-08-07
EP0386839B1 (de) 1997-01-15
IL93610A0 (en) 1990-12-23
NO901082D0 (no) 1990-03-07
JPH0334969A (ja) 1991-02-14

Similar Documents

Publication Publication Date Title
US5559125A (en) Hydroxyquinolone derivatives
US6608083B1 (en) Quinoline derivatives(2)
US6743804B2 (en) Quinoline derivatives as NK3 antagonists
DE69029668T2 (de) Tetrahydroquinolin-Derivate, verwendbar bei neurodegenerativen Krankheiten
WO2019120210A1 (zh) 一类苯并呋喃及Coumestans衍生物及其制备方法和应用
OA10331A (en) Condensed-ring thiophene derivatives their production and use
US5231102A (en) Tetrahydroquinoline derivatives useful for neurodegenerative disorders
US5268378A (en) Dioxo-tetrahydroquinoline derivatives
EA008801B1 (ru) Получение арилалкилкарбаматных производных и их применение в терапии
CA2043367A1 (en) Dioxo-tetrahydroquinoline derivatives
JP2006508116A (ja) Ｌｔｄ４アンタゴニストとしての新規三環式誘導体
DK149230B (da) Analogifremgangsmaade til fremstilling af 5-benzoyl-6-hydroxy-indan-1-carboxylsyrederivater eller farmaceutisk acceptable salte deraf
US5250540A (en) Aminomethyl-substituted 2,3-dihydropyrano[2,3-b]pyridines and their use in medicaments
WO2013106756A2 (en) Antimicrobial agents
US7442793B2 (en) Peptide deformylase inhibitors
AU2114600A (en) Tetrahydroindazole derivatives as ligands for gaba-a alpha 5 receptors
DK156066B (da) Analogifremgangsmaade til fremstilling af oxaloamino- eller hydroxyacetylaminobenzopyranderivater eller salte deraf med baser
CN102924448B (zh) 生物碱cryptolepine类似物吲哚并喹啉酸化合物及制备方法
CA2126076A1 (en) Nitroquinolone derivatives as nmda antagonists
JPH03188060A (ja) アニリン類及びベンジルアミン類から得られるベンジルセレノベンズアミド類、及びその製造方法
CA2202135A1 (en) Pyridazinoquinoline compounds
SI9300202A (sl) Derivati hidroksikinolona
US20040097518A1 (en) Quinoline derivatives as nk-3 antagonists
TW201920132A (zh) 用於製造藥物之新穎化合物